Antibody Drug Conjugates Conference 2018
November 12 - 13, 2018
Lisbona , Portogallo
As more Antibody-Drug Conjugates head to market, the next-generation of ADCs looms on the horizon. Next-gen engineering requires designing an optimal antibody, payload, linker and conjugation method while ensuring stability, targeted delivery, and limited off-target effects. The “Next-Generation Antibody-Drug Conjugates” conference explores the engineering finesse required to achieve improved therapeutics while adhering to the underlying biology that research has uncovered, showing the way to more potent and efficacious molecules. Case Studies and data will be shared that exemplify the ongoing efforts to engineer ADCs, move them into the clinic, and fight cancer along with potentially non-oncological indications.
Organizzatore
Eventi correlati
Antibody Drug Conjugates Conference November 12 - 13, 2018